Clinical trial Recruiting at 1 site Interventional Ages 7 to 11

Cognitive-behavioral therapy with and without sleep restriction for insomnia in children aged 7-11

Official title: The Role of Sleep Restriction Therapy in Cognitive-behavioral Therapy for Insomnia in School-aged Children: A Randomized Controlled Trial

Run by Tel Aviv University · NCT07048340 · Data updated 2026-11-12

This project will test whether adding sleep restriction to CBT-I helps children aged 7-11 with chronic insomnia sleep better.

Quick facts

Study typeInterventional
Ages7 Years to 11 Years
SexAll
Enrollment120 (estimated)
SponsorTel Aviv University
Academic / other
Locations1 site (Tel Aviv, Israel)
StatusRecruiting
StartedJuly 10, 2025
Main results expectedJanuary 1, 2029
Study endsDecember 1, 2029
Registry record updatedSeptember 18, 2025
Trial IDNCT07048340 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 7–11 who meet ICSD-3 criteria for chronic insomnia (symptoms ≥3 nights/week for ≥3 months), average at least 6 hours of sleep per night at baseline, have parents over 18, can read and write Hebrew, and are not on sleep or psychotropic medications or receiving concurrent CBT.

Probably not a fit

Children with medical sleep disorders (e.g., OSA, RLS), significant neurodevelopmental or health problems, those on sleep/psychotropic medications, non-Hebrew speakers, or those averaging under 6 hours of sleep per night are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, dismantling trial will assign children 7-11 with chronic insomnia to one of three groups: full CBT-I (including sleep restriction), CBT-I without sleep restriction, or a waitlist control. Sleep and insomnia outcomes will be measured with actigraphy, sleep diaries, a diagnostic interview, and parent/child questionnaires at baseline, mid-treatment, post-treatment, and 3-month follow-up, and some measures (e.g., child motivation) will be collected after each session. The design specifically tests the incremental benefit of sleep restriction therapy and examines mediators (pre-sleep hyperarousal and parental over-accommodation) and a moderator (child motivation). The trial aims to clarify which CBT-I components drive clinical change in school-aged children and inform parent-involved treatment strategies.

Why it matters

Potential benefit: If successful, the study could show whether including sleep restriction improves CBT-I outcomes for children and help clinicians deliver a more effective, targeted treatment.

How similar studies have gone: CBT-I and sleep restriction have strong evidence in adults and some supportive data in older youth, but CBT-I in school-aged children and the specific added value of sleep restriction remain largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Child aged 7-11 years
* Parents aged over 18 years
* Child meets the International Classification of Sleep Disorders - Third Edition (ICSD-3) criteria for chronic insomnia disorder with sleep difficulties occurring at least 3 times a week and lasting at least 3 months (Insomnia diagnosis will be determined during a clinical interview).

Exclusion Criteria:

* Child receiving concurrent CBT treatment for sleep or anxiety disorders.
* Child diagnosed with a medical sleep problem (e.g., OSA, RLS)
* Significant health or neurodevelopmental problems (e.g., intellectual disability)
* Current psychotropic medications, or sleep aid medications
* Lack of Hebrew reading and writing
* Total sleep time that is shorter than 6 hours on average per night at baseline

Where it's running

  • Tel Aviv University
    Tel Aviv, Israel, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.